aceA machine learning-derived sarcopenia index is associated with survival and nonrelapse mortality in DLBCL
Abstract Body composition analysis (BCA) provides an objective assessment of metabolic states, but its prognostic value in diffuse large B-cell lymphoma (DLBCL) remains unclear. We applied machine learning-supported BCA to computed tomography imaging from patients with newly diagnosed DLBCL enrolled in the prospective phase 3 PETAL trial to quantify radiologic sarcopenia. We assessed BCA results in relation to survival after first-line immunochemotherapy, treatment-related hematologic toxicities, and molecular d…
Machine learning-supported body composition analysis applied to CT imaging quantifies radiologic sarcopenia and enables risk stratification for survival after first-line immunochemotherapy in newly diagnosed DLBCL.
Evidence
- Peer-reviewedBlood Advances2026-09-01
How should this claim be treated?
Truvace Impact Record TRV-2026-0948, v2: “A machine learning-derived sarcopenia index is associated with survival and nonrelapse mortality in DLBCL.” Truvace, 2026-10-26. /record/TRV-2026-0948 (accessed at citation time). sha256 33fe9178c0745af4…
Calibration history
Every change to this record since certification, in the open.
Direction audit: filed as a problem but describes a gain.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-0948 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.